1 hour ago
Novo Nordisk (NVO) Stock Jumps After Q1 Earnings Crush Estimates on Oral Wegovy Success
Novo Nordisk (NVO) shares climb after Q1 earnings beat estimates with $15.17B revenue. Oral Wegovy pill crosses 2M prescriptions, boosting 2026 outlook.
The post Novo Nordisk (NVO) Stock Jumps After Q1 Earnings Crush Estimates on Oral Wegovy Success appeared first on Blockonomi.
Source: Blockonomi →Related News
- 35 minutes ago
Disney (DIS) Q2 Earnings: Streaming Growth and New CEO D’Amaro Take Center Stage
- 41 minutes ago
Intel (INTC) Stock Soars 13% in One Day: Should Investors Buy the Dip or Sell th...
- 42 minutes ago
MercadoLibre (MELI) Stock: Analyst Expectations Ahead of Thursday’s Q1 Report
- 55 minutes ago
Gold Surges 2.3% on U.S.-Iran Diplomatic Progress and Weakening Dollar
- 1 hour ago
Crude Oil Plunges 6% on Prospects of U.S.-Iran Peace Agreement and Hormuz Reopen...